A gain of function by the cancer-associated FGFR4 c. 1162G>A (p. Gly388Arg) variant

被引：0
|
作者：
Ulaganathan, V. K. [1 ]
Sperl, B. [1 ]
Mayr, T. [1 ]
Hornberger, R. [1 ]
Rapp, U. R. [2 ]
Ullrich, A. [1 ]
机构：
[1] Max Planck Inst Biochem, Mol Biol, D-82152 Martinsried, Germany
[2] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)50398-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
446
引用
收藏
页码：S107 / S108
页数：2
相关论文
共 25 条
  • [1] FGFR4 Gly388Arg polymorphism and prognosis of breast and colorectal cancer
    Spinola, M
    Leoni, VP
    Tanuma, JI
    Pettinicchio, A
    Frattini, M
    Signoroni, S
    Agresti, R
    Giiovanazzi, R
    Pilotti, S
    Bertario, L
    Ravagnani, F
    Dragani, TA
    ONCOLOGY REPORTS, 2005, 14 (02) : 415 - 419
  • [2] Is FGFR4 Gly388Arg missense variant a suitable prognostic marker in neuroblastoma?
    Katarzyna, Szewczyk
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (02) : 355 - 358
  • [3] Fibroblast growth factor receptor 4 (FGFR4) variant p. Gly388Arg in Czech children carcinoma patients
    Valaskova, I.
    Drabova, K.
    Spesna, R.
    Gaillyova, R.
    Sterba, J.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1899 - 1899
  • [4] FGFR4 Gly388Arg polymorphism and prostate cancer risk in Scottish men
    Ho, C. K. M.
    Anwar, S.
    Nanda, J.
    Habib, F. K.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2010, 13 (01) : 94 - 96
  • [5] FGFR4 Gly388Arg polymorphism and prostate cancer risk in Scottish men
    C K M Ho
    S Anwar
    J Nanda
    F K Habib
    Prostate Cancer and Prostatic Diseases, 2010, 13 : 94 - 96
  • [6] FGFR4 GLY388ARG polymorphism modulates cancer patients' survival in pooled analysis
    Elisa Frullanti
    Tommaso A Dragani
    BMC Proceedings, 4 (Suppl 2)
  • [7] Investigation of FGFR4 (Gly388Arg) Gene Polymorphism in Primary Lung Cancer Patients
    Ture, Mehmet
    Yakut, Tahsin
    Deligonul, Adem
    Karkucak, Mutlu
    Sag, Sebnem Ozemri
    Hartavi, Mustafa
    Cubukcu, Erdem
    Gulten, Tuna
    Evrensel, Turkkan
    INTERNATIONAL JOURNAL OF HUMAN GENETICS, 2015, 15 (01) : 7 - 12
  • [8] Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor
    Frullanti, Elisa
    Berking, Carola
    Harbeck, Nadia
    Jezequel, Pascal
    Haugen, Aage
    Mawrin, Christian
    Parise, Orlando, Jr.
    Sasaki, Hidefumi
    Tsuchiya, Norihiko
    Dragani, Tommaso A.
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2011, 20 (04) : 340 - 347
  • [9] FGFR4 c.1162G > A (p.Gly388Arg) Polymorphism Analysis in Turkish Patients with Retinoblastoma
    Akdeniz Odemis, Demet
    Tuncer, Seref Bugra
    Adamnejad Ghafour, Arash
    Jabbarli, Khariga
    Gider, Yasemin
    Celik, Betul
    Kuru Turkcan, Gozde
    Sukruoglu Erdogan, Ozge
    Kilic Erciyas, Seda
    Avsar, Mukaddes
    Kebudi, Rejin
    Buyukkapu Bay, Sema
    Tuncer, Samuray
    Yazici, Hulya
    JOURNAL OF ONCOLOGY, 2020, 2020
  • [10] Polymorphism of FGFR4 Gly388Arg Does Not Confer an Increased Risk to Breast Cancer Development
    Naidu, R.
    Har, Y. C.
    Taib, N. A.
    ONCOLOGY RESEARCH, 2009, 18 (2-3) : 65 - 71
123